
    
      Approximately 180 patients at least 12 years of age with facial acne will be randomized to
      twice daily topical treatment with 0.1% or 0.025% ASC-J9 cream or vehicle control for 12
      weeks. Patients will return to the clinic at Weeks 2, 4, 8 and 12 and again 4 weeks after the
      last dose of study drug for evaluation of acne status and safety parameters.
    
  